EXPO (NASDAQ: EXPO) files notice for proposed restricted stock sale
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
EXPO files a Form 144 notice reporting proposed sales of restricted common stock.
The filing lists three restricted stock lots of 594, 568 and 510 shares with grant dates 03/11/2022, 03/11/2026 and 03/12/2021
Positive
- None.
Negative
- None.
Key Figures
Restricted lot: 594 shares
Restricted lot: 568 shares
Restricted lot: 510 shares
+4 more
7 metrics
Restricted lot
594 shares
grant date 03/11/2022
Restricted lot
568 shares
grant date 03/11/2026
Restricted lot
510 shares
grant date 03/12/2021
Filing date
05/19/2026
date shown in header
Broker/issuer line numeric
1672
field present in issuer information
Numeric field
98062.13
field present in issuer information
Numeric field
48511629
field present in issuer information
Key Terms
Restricted Stock, Securities To Be Sold, Issuer
3 terms
Restricted Stock financial
"Common | 03/11/2022 | Restricted Stock | Issuer"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Securities To Be Sold regulatory
"144: Securities To Be Sold"
Issuer regulatory
"Restricted Stock | Issuer | | | 594"
FAQ
What does EXPO's Form 144 disclose?
It discloses proposed sales of restricted common stock by EXPO. The notice lists three lots of restricted shares: 594, 568, and 510 with corresponding grant dates shown in the filing.
Who is listed as the issuer or broker in the Form 144 for EXPO?
The filing lists Morgan Stanley Smith Barney LLC with an address at 1 New York Plaza, New York. That broker/dealer appears in the issuer/broker line of the notice as provided.
What securities and grant dates are shown in the EXPO filing?
The securities are identified as Common restricted stock with grant dates 03/11/2022, 03/11/2026, and 03/12/2021 and the listed share counts of 594, 568 and 510.
Does the Form 144 state transaction proceeds or sale timing?
The notice lists the restricted stock lots and grant dates but it does not provide price, proceeds, or a sale execution date in the excerpted lines shown in the content.